BA
ELAN icon

Bennicas & Associates’s Elanco Animal Health ELAN Stock Holding History

Bennicas & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,353
Closed -$191K – 98
2022
Q3 		$191K Sell
15,353
-800
-5% -$14K 0.12% 89
2022
Q2 		$317K Sell
16,153
-153
-0.9% -$3.62K 0.19% 79
2022
Q1 		$425K Hold
16,306
– – 0.21% 81
2021
Q4 		$463K Buy
16,306
+536
+3% +$16.7K 0.24% 82
2021
Q3 		$503K Sell
15,770
-2
-0% -$67 0.28% 78
2021
Q2 		$547K Hold
15,772
– – 0.3% 76
2021
Q1 		$464K Buy
15,772
+7,512
+91% +$231K 0.27% 78
2020
Q4 		$253K Buy
+8,260
New +$252K 0.15% 88

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bennicas & Associates's ELAN Position: Q4 2022 in Review

Bennicas & Associates sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 15,353 shares — an estimated $191K sold.

Bennicas & Associates first reported a position in ELAN in Q4 2020 and held it in 8 quarters. The position peaked at $547K in Q2 2021. 403 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Bennicas & Associates reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Bennicas & Associates sold 15,353 Elanco Animal Health shares in Q4 2022, an estimated $191K.
  • Bennicas & Associates first reported a position in Elanco Animal Health in Q4 2020 and held it in 8 quarters.
  • Bennicas & Associates's Elanco Animal Health position peaked at $547K in Q2 2021.
  • 403 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.